Virtual consulting · Worldwide
NeuciteConsultingRequest a quote

Target product profiles that guide development decisions

Not sure what good enough means for your product? We turn it into one profile for biotech, device, cosmetic and drug-delivery teams: minimum and target values, the test that proves each, and go/no-go gates.

Decide what success looks like before you build it

A target product profile states what a product must do to be worth developing. It lists the intended use, the users, the key performance and safety attributes, and the value each must reach. Good profiles give two numbers per attribute: a minimum acceptable value and a target value. Development can then be judged against the profile at each stage, and work that cannot reach the minimum stops early.

The concept is well established in drug development, where it is widely used as a strategic planning tool. For drug products, ICH Q8(R2) defines the quality target product profile: a prospective summary of the quality characteristics needed to deliver the intended safety and efficacy. The same discipline works for medical devices, biomaterials, cosmetics and nutraceuticals. There it feeds design inputs and product requirements.

Our contribution is technical depth. We translate each attribute into something measurable, choose a test method, and check that the values are realistic for the materials and formulation you plan to use. We also flag attributes that can drive regulatory classification, such as claims, mechanism of action or degradation behavior. The result is a profile that scientists, investors and regulatory teams can all use.

What you receive

01

Draft product profile

A structured profile covering intended use, users, performance, safety, usability, stability, manufacturing and commercial attributes. Each row has a minimum acceptable value, a target value and the rationale behind both.

02

Attribute-to-method map

For every attribute, the test method or evidence source that will show whether it is met. It includes standards where they apply, sample sizes, and the development stage at which each test belongs.

03

Feasibility check

A technical review of whether the targets are realistic for the chosen materials, formulation or platform, using the literature, comparable products and your data. Unrealistic targets are flagged with suggested alternatives.

04

Regulatory flags

A short list of attributes and claims that may influence product classification or evidence requirements in your target markets. It is prepared for your regulatory team or advisers to confirm.

05

Stage-gate criteria

Decision criteria linked to the profile for each development stage. They state which data must exist, which values must be met and who decides, turning the profile into a management tool.

06

Investor and partner version

A concise external version that explains intended performance and differentiation without exposing confidential formulation or process details. It supports diligence and partnering discussions with a consistent story.

How we build a profile with your team

Gather the inputs

We gather written input from your scientific, clinical, and commercial leads and review existing data, competitor products, and unmet needs. This shows where the team agrees, where it does not, and which assumptions are untested.

Draft and quantify

We write the profile with minimum and target values, map each attribute to a test method, and check feasibility against materials science and published data. Gaps and conflicts are listed for discussion.

Align and maintain

We run a review session with your team to agree values and priorities. The profile is then versioned, so later data can update it and every change to a target is documented.

How this work typically looks

A

Medical device start-up

One profile for a bioresorbable chronic-wound dressing

Situation
A team developing a bioresorbable dressing for chronic wounds has separate wish lists from its scientists, clinical advisers and business lead. Nobody agrees on resorption time, fluid handling or shelf life. Laboratory work continues without a clear definition of success.
How we advise
We draft a single profile with minimum and target columns for absorbency, moisture vapor transmission, resorption time, mechanical integrity, conformability, sterility, biocompatibility and shelf life. Each attribute is mapped to a standard test method or a justified in-house test. We check resorption targets against the polymer's known degradation behavior and flag attributes that affect device classification.
What you receive
A versioned profile document, an attribute-to-method map, a feasibility note on resorption and fluid handling, and a list of open questions for clinical advisers.
B

Drug-delivery start-up

Preparing a product profile for investor and partner talks

Situation
A start-up with a sustained-release platform is preparing for investor meetings and partnering talks. Its pitch describes the technology well but not the product. Potential partners keep asking what dose, duration, route and stability the first product will deliver.
How we advise
We build an internal profile from the platform data, covering dose, release duration, route, injection volume, stability, storage and manufacturing attributes. We compare the targets with existing treatments to show where the product would differ. We then prepare an external version for diligence that avoids confidential formulation details. Uncertain values are labeled as targets, not results.
What you receive
An internal profile, a partner-facing summary, a comparison with current treatment options, and a list of the data partners are likely to request next.
C

Cosmetic ingredient supplier

Defining a cosmetic active product across several markets

Situation
A supplier has a new plant-derived active and wants to launch a finished product in several markets. Claims, texture, stability and regulatory status have been discussed separately. Some planned claims may push the product outside the cosmetic category in certain markets.
How we advise
We build a profile around the consumer benefit, with attributes for claims, active concentration, sensory feel, pH, appearance, stability and packaging compatibility. Each claim is tagged with the evidence it needs. We flag claims that may imply drug-like activity and note the regulatory status questions for each market. Your regulatory team or local advisers confirm the final positions.
What you receive
A product profile with market-specific notes, a claims-to-evidence map, stability and sensory targets, and a list of regulatory questions to resolve before launch.

Illustrative scenarios. Each is a composite of common client situations, not a specific engagement.

Frequently asked questions

Can we just use a TPP template?

A template is a useful start, but it cannot tell you which values are realistic or how to measure them. Most of the value comes from quantifying each attribute and testing it against your data and the materials you plan to use. We work from your product, not from a blank form.

When should we write a target product profile?

As early as possible, ideally before major formulation or design work begins. An early profile can be rough, with wide ranges and open questions. It becomes sharper as data arrive. Teams that wait until late development often find that earlier work optimized the wrong attributes.

Is a target product profile a regulatory document?

Not usually. It is an internal planning tool, although parts of it may inform regulatory meetings, design inputs or a quality target product profile for a drug. We prepare the technical content. Regulatory strategy and classification decisions should be confirmed by your regulatory team or advisers.

What do you need from us?

Any existing product descriptions, prototype data, competitor or comparator information, and the intended markets and users. Written input from two or three key people helps clarify priorities. Timing depends mostly on how many stakeholders need to agree and how much data already exists.

What happens once the profile is agreed?

The profile becomes the reference for development decisions. Many teams then use its go/no-go criteria to set stage gates, or move into formulation and characterization work against the agreed targets. We can revisit the profile when major data arrive, so it stays current rather than becoming a forgotten document.

What happens after I contact you?

A scientist follows up by email about the product, intended users, stakeholders, and existing data. A rough concept is enough to start scoping. We send a written quote for your approval before work begins.

Need a clear definition of your product?

Share what you’re building and who it’s for. We’ll outline what the working profile would cover and send a written quote.

Regulatory flags in a product profile are technical observations for your regulatory team; we do not make classification decisions or provide legal opinions.